|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Cangene Corporation (CC:CNJ) Announces Amendment to Normal Course Issuer Bid
11/12/2009 11:27:07 AM
TORONTO and WINNIPEG, Nov. 12 /CNW/ - Cangene Corporation (the "Corporation") today announces that the Toronto Stock Exchange (the "TSX") has approved an amendment to the Corporation's Normal Course Issuer Bid (the "Bid") to increase the maximum number of common shares of the Corporation ("Common Shares") available for purchase under the Bid from 1,000,000 Common Shares to 1,500,000 Common Shares, representing 2.19% of the outstanding Common Shares on April 20, 2009, which is the date of the Notice of Intention to Make a Normal Course Issuer Bid. At April 20, 2009, there were 68,481,670 Common Shares issued and outstanding.
|
|
|
|
|
|
|
|
|
|
|